health.economictimes.indiatimes

Lupin launches Luforbec 100/6 for adult asthma, COPD treatment in Germany

Luforbec 100µg/6µg pMDI is indicated for adult asthma and COPD treatment, where the use of an inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) is suitable. With the same active ...
PharmiWeb

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes their commitment to ...

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec ® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes their commitment to supporting the NHS green ...
PharmiWeb

Luforbec® 100/6 (beclometasone 100mcg / formoterol 6mcg) pMDI, first branded generic alternative to Fostair® 100/6 pMDI to treat Asthma & COPD, is now available in the UK

Luforbec ® 100/6 (beclometasone 100mcg / formoterol 6mcg) pMDI, first branded generic alternative to Fostair ® 100/6 pMDI to treat Asthma & COPD, is now available in the UK Lupin continues their ...
The Free Press Journal

Lupin Launches Luforbec 100/6 For Adult Asthma And COPD Treatment In Germany

Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / formoterol 6 µg), a fix combination in a pressurized metered ...